Acta rheumatologica - Institut za reumatologiju

60. Toivanen A. Reactive arthritis: clinical features and treatment. U: Rheumatology, eds Hochberg MC,
Silman AJ, Smolen JC, Weinblatt WE, Weisman MH. Mosby, Edinburg 2003;1233-1240.
61. Mladenović V. Klinička, radiološka i imunogenetska obeležja postkolitisnog i urogenitalnog oblika
Reiterovog sindroma. Acta rheum Belgrad 1986;16:23-33.
62. Sideljnikova SM. Kliniko-patogenetičeskie aspekti reaktivnih artritov pri nekotorih kišečnjih i
urogenjitaljnih infekcijah. Disertacija kandidata medicinskih nauk, Akademija medicinskih nauk
SSSR, Moskva, 1981;1-28.
63. Hannu T, Kauppi M, Tuomala M et al. Reactive artrhtitis following an outbreak of Campylobacter
jejuni infection. J Rheumatol 2004;31:528-530.
64. Leirisalo-Repo M, Helenius P, Hannu T et al. Long term prognosis of reactive salmonella arthritis.
Ann Rheum Dis 1997;56:516-520.
65. Roganović M, Mladenović V, Petrović R. Nepotpuni oblik Reiterovog sindroma s oboljenjem
lokomotornog sistema kao jedine manifestacije Reiterovog sindroma. X kongres reumatologa
Jugoslavije, Zbornik plenarnih predavanja i rezimea radova. Institut za reumatologiju, Beograd. 1988;
S-107.
66. Aho K, Ahvonen P, Lassus A et al. HL-A27 in reactive arthritis. A study of yersinia arthritis and
Reiter's disease. Arthritis Rheum 1974;17:521-526.
67. Lauhio A, Leirisalo-Repo M, Lähdevirta J et al. Double-blind, placebo-controlled study of threemonth
treatment with Lymecycline in reactive arthritis, with special reference to chlamydia arthritis.
Arthritis Rheum 1991;34:6-14.
68. Bardin T, Schumacher RH. Should we treat postvenereal Reiter's syndrome by antibiotics? J
Rheumatol 1991;18:1780-1782.
69. Panay GS, Clark B. Monocycline in the treatment of patients with Reiter's syndrome (letter). Clin Exp
Rheumatol 1989;7:100-101.
70. Williams R, Harrison HR, Tempest B, Rizzoli A. Chlamydial infection and arthritis (letter). J
Rheumatol 1989;16: 846-847.
71. Wollenhaupt J, Hammer M, Pott HG, Zeidler H.A double-blind, placebo controlled comparison of 2
weeks versus 4 months treatment with doxacycline in Chlamydia-induced reactive artrhritis (abstract).
Arthritis Rheum 1997; 40, suppl 9:S 143.
72. Wakefield D, McCluskey P. Verma M et al. Ciprofloxacin treatment does not influence course of
relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999; 432:1894-1897.
73. Sieper J, Fendler C, Laitko S et al. No benefit of long-term ciprofloxacin treatment in patients with
reactive arthritis and undifferentiated oligoarthritits. Arthritis Rheum 1999;42:1386-1396.
74. Hoogkamp-Korsanje JAA, Moesker H, Bruyn GAW. Ciprofloxacin v. placebo for treatment of
Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis 2000;59:914-917.
75. Yli-Kerttula T, Luukkainen R, Yli-Krttula U et al. Effect of a three month course of ciprofloxacin on
the outcome of reactive arthritis. Ann Rheum Dis 2000;59:565-570.
76. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive
arthritis. Ann Rheum Dis 2003;62:655-658.
77. Sieper J, Braun J. Treatment of reactive arthritis with antibiotics. Br J Rheumatol 1998;37:717-720.
78. Toivanen A. Managing reactive arthritis. Rheumatology 2000;39:117-121.
79. Zeidler H, Kuipers J, Köhler L. Chamydia-induced arthritis. Curr Opin Rheum 2004;16:380-392.
80. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta
Rheum Scand 1969;15:232-253.
81. Aho K, Ahvonen P, Lassus A et al. HL-A27 in reactive arthritis. A study of yersina arthritis and
Reiter's disease. Arthritis Rheum 1974;17:521-526.
82. Mladenović V. Reiterov sindrom - infekcijski artritis? Balneoclimatologia 1998;supl 1:29-33.
83. Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis: a current view. Sem Arthritis Rheum
1994;24:190-210.